Xie Lu,Xu Jie,Sun Xin, et al. ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma. [J].JOURNAL OF CLINICAL ONCOLOGY,2024,42(16).
APA:
Xie Lu,Xu Jie,Sun Xin,Liang Xin,&Tang Xiaodong.(2024).ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma. .JOURNAL OF CLINICAL ONCOLOGY,42(16).
MLA:
Xie Lu, et al. "ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma." .JOURNAL OF CLINICAL ONCOLOGY 42,16(2024).